Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $528000.0.

  • Catheter Precision's Depreciation & Amortization (CF) fell 37.74% to $528000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 114.56%. This contributed to the annual value of $2.1 million for FY2024, which is 163.86% up from last year.
  • Catheter Precision's Depreciation & Amortization (CF) amounted to $528000.0 in Q3 2025, which was down 37.74% from $529000.0 recorded in Q2 2025.
  • Catheter Precision's Depreciation & Amortization (CF)'s 5-year high stood at $1.4 million during Q1 2023, with a 5-year trough of -$406000.0 in Q2 2023.
  • In the last 5 years, Catheter Precision's Depreciation & Amortization (CF) had a median value of $517000.0 in 2023 and averaged $408315.8.
  • The largest annual percentage gain for Catheter Precision's Depreciation & Amortization (CF) in the last 5 years was 196800.0% (2023), contrasted with its biggest fall of 39852.94% (2023).
  • Catheter Precision's Depreciation & Amortization (CF) (Quarter) stood at $315000.0 in 2021, then tumbled by 92.06% to $25000.0 in 2022, then skyrocketed by 1968.0% to $517000.0 in 2023, then rose by 2.71% to $531000.0 in 2024, then fell by 0.56% to $528000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $528000.0 in Q3 2025, compared to $529000.0 in Q2 2025 and $531000.0 in Q1 2025.